The last authors suggested that some help in counteracting tumour resistance to treatment in lung cancer patient could come from an IL‐4 blockade, and according to our results this adjuvant treatment could surely be of great help to overcome resistance and delay recurrence in non‐responding NPC patients. The gene discussed is IL4; the disease is lung carcinoma.